Skip to main content
  • Editorial: I'll Take My PCI to Go

    The evolution of percutaneous coronary intervention (PCI) with advances in equipment, optimized anticoagulation, antiplatelet drug strategies, and improved vascular access and hemostasis techniques has led to more predictable angiographic and clinical outcomes. This has allowed for the consideration of same-day discharge following PCI (SDPCI) [  ]. Already popular in many countries, the adoption of SDPCI (defined as discharge on the same calendar day as the PCI procedure) has been gaining momentum in the United States. Between 2006 and 2015, SDPCI increased from 0.5% to 3.5% and appears to have further increased to 14% in 2017 as reported in one survey of US Interventional Cardiologists — albeit with wide inter-institutional disparity in adoption [  ,  ]. This shift toward SDPCI has been motivated by the economic advantage—realized by treating institutions, as incurred costs are significantly attenuated with SDPCI as compared with an overnight “observation” stay (ONPCI). Amin et al. reported a more than $5000 per patient benefit with SDPCI compared to ONPCI [  ]. The RASADDA-PCI trial reported a 30-day cumulative total cost benefit of $4493.22 for SDPCI vs. ONPCI (p < 0.001) [  ]. There is also a strong patient preference for a same-day approach [  ].

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details